Literature DB >> 10323765

Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix.

U Lundstam1, E Hurt-Camejo, G Olsson, P Sartipy, G Camejo, O Wiklund.   

Abstract

Lp(a) interference with fibrinolysis could contribute to atherothrombosis. Additionally, accumulation of Lp(a) and LDLs, could lead to cholesterol deposition and foam cell formation in atherogenesis. The interactions between Lp(a) and LDL could cause their entrapment in the extracellular matrix of lesions. We found that association of Lp(a) with matrix secreted by cultured human arterial smooth muscle cells increased 2 to 3 times the subsequent specific binding of radioactive LDL. Chondroitin sulfate proteoglycans seem responsible for formation of the specific matrix-Lp(a) and matrix-LDL aggregates. The proteoglycans appeared also to participate in a cooperative increase of radioactive LDL binding to matrix pretreated with Lp(a). In the matrix preincubated with LDL, approximately 50% of the additional lipoprotein was bound by ionic interactions. In the matrix preincubated with Lp(a), 20% of the additional LDL was held by ionic bonds, and the rest was held by strong nonionic associations. Binding analysis in physiological solutions confirmed that chondroitin sulfate-rich proteoglycans from the smooth muscle cell matrix have a high affinity for Lp(a) and LDL. The results provide an explanation to the observed localization of Lp(a) and LDL in the extracellular matrix of arterial lesions and suggest a mechanism for their cooperative accumulation there.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323765     DOI: 10.1161/01.atv.19.5.1162

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Efficacy and safety of statins in hypercholesterolemia with emphasis on lipoproteins.

Authors:  San-Chiang Wu; Jeng-Chuan Shiang; Shoa-Lin Lin; Te-Lang Wu; Wei-Chun Huang; Kuan-Rau Chiou; Chun-Peng Liu
Journal:  Heart Vessels       Date:  2005-09       Impact factor: 2.037

Review 2.  The role of lipoprotein[a] in atherosclerosis.

Authors:  J D Morrisett
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

3.  Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions.

Authors:  Rogier A van Dijk; Frank Kolodgie; Amir Ravandi; Gregor Leibundgut; Patrick P Hu; Anand Prasad; Ehtisham Mahmud; Edward Dennis; Linda K Curtiss; Joseph L Witztum; Bruce A Wasserman; Fumiyuki Otsuka; Renu Virmani; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2012-09-11       Impact factor: 5.922

Review 4.  The pigeon (Columba livia) model of spontaneous atherosclerosis.

Authors:  J L Anderson; S C Smith; R L Taylor
Journal:  Poult Sci       Date:  2014-09-11       Impact factor: 3.352

5.  Lipoprotein(a): biology and clinical importance.

Authors:  Sally P A McCormick
Journal:  Clin Biochem Rev       Date:  2004-02

6.  Lipoprotein(a) as a cardiovascular risk factor: current status.

Authors:  Børge G Nordestgaard; M John Chapman; Kausik Ray; Jan Borén; Felicita Andreotti; Gerald F Watts; Henry Ginsberg; Pierre Amarenco; Alberico Catapano; Olivier S Descamps; Edward Fisher; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2010-10-21       Impact factor: 29.983

7.  Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids.

Authors:  Monika Sharma; Anne Von Zychlinski-Kleffmann; Carolyn M Porteous; Gregory T Jones; Michael J A Williams; Sally P A McCormick
Journal:  J Lipid Res       Date:  2015-04-06       Impact factor: 5.922

8.  Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).

Authors:  Konstantin A Krychtiuk; Stefan P Kastl; Sebastian L Hofbauer; Anna Wonnerth; Georg Goliasch; Maria Ozsvar-Kozma; Katharina M Katsaros; Gerald Maurer; Kurt Huber; Elisabeth Dostal; Christoph J Binder; Stefan Pfaffenberger; Stanislav Oravec; Johann Wojta; Walter S Speidl
Journal:  J Clin Lipidol       Date:  2015-04-25       Impact factor: 4.766

Review 9.  The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina.

Authors:  Tina Z Khan; Alison Pottle; Dudley J Pennell; Mahmoud S Barbir
Journal:  Glob Cardiol Sci Pract       Date:  2014-01-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.